(Q37845097)

English

Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses?

scientific article published on December 2012

Statements

Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses? (English)
Gregory K Pennock
William Waterfield
1 December 2012
606-611

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit